|
MIER1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00840000016866E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.76379999997189E-06 |
| Normal-vs-Stage2 |
1.60309999999164E-05 |
| Normal-vs-Stage3 |
3.44880000002767E-06 |
| Normal-vs-Stage4 |
6.77529999881799E-08 |
| Stage1-vs-Stage2 |
1.403970E-01 |
| Stage1-vs-Stage3 |
2.980800E-01 |
| Stage1-vs-Stage4 |
3.392400E-02 |
| Stage2-vs-Stage3 |
5.504000E-01 |
| Stage2-vs-Stage4 |
6.473000E-01 |
| Stage3-vs-Stage4 |
2.083800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.50609999974394E-07 |
| Normal-vs-AfricanAmerican |
3.998500E-02 |
| Normal-vs-Asian |
5.5106000000027E-05 |
| Caucasian-vs-AfricanAmerican |
2.267400E-01 |
| Caucasian-vs-Asian |
8.555000E-01 |
| AfricanAmerican-vs-Asian |
2.146600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.82710000029962E-07 |
| Normal-vs-Female |
4.13820000044751E-07 |
| Male-vs-Female |
8.013600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.81090000000484E-05 |
| Normal-vs-Age(41-60Yrs) |
6.89079999727227E-08 |
| Normal-vs-Age(61-80Yrs) |
4.11429999958024E-07 |
| Normal-vs-Age(81-100Yrs) |
5.922300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.688200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.783600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.733800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.364800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.850600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.840400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.134760E-01 |
| Classical-VS-Follicular |
1.156450E-03 |
| Classical-VS-Other |
3.582000E-01 |
| Classical-VS-Normal |
4.46560000000318E-05 |
| Tall-VS-Follicular |
6.321600E-01 |
| Tall-VS-Other |
9.212400E-01 |
| Tall-VS-Normal |
1.238910E-04 |
| Follicular-VS-Other |
8.696800E-01 |
| Follicular-VS-Normal |
2.64670000360567E-08 |
| Other-VS-Normal |
1.998340E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.74950000545005E-08 |
| Normal-vs-N1 |
2.29139999996519E-06 |
| N0-vs-N1 |
9.998800E-01 |
|
|
